OREXIGEN THERAPEUTICS (Stock Symbol: OREX)
OREX- Stock Profile
|Company Name:||OREXIGEN THERAPEUTICS|
|Stock Ticker (Symbol):||OREX|
|Traded Exchange:||NASDAQ Stock Exchange|
|Average Traded Price:||$6.16|
|Average Daily Traded Volume:||781,100|
|Started to Trade on:||Monday, April 30, 2007|
OREXIGEN THERAPEUTICS Profile
Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its lead combination product candidates include Contrave, which has completed Phase III clinical trials; and Empatic that has completed Phase II clinical trials. Contrave is a combination of two drugs, bupropion and naltrexone, in a sustained release formulation (SR). Bupropion is an antidepressant and smoking cessation medication; naltrexone is a treatment for alcohol and opioid addiction. The company's Empatic product candidate is a combination of bupropion SR and zonisamide SR. Zonisamide, in an immediate release formulation for the adjunctive treatment of partial seizures, a form of epilepsy. The company was founded in 2002 and is based in La Jolla, California.
|OREX Charts||OREX Quotes||OREX Analysis||OREX Price|
You are logged Out of the Members' Area
To have access to real-time quotes, charts, trading signals and fresh market outlook you have to be logged in:
Not a member yet?
Click here to become a full member of MarketVolume® and enjoy the benefits of a feature rich market timing system!
No, Thanks, I would like to check the website first.